3Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease[J]. Nature, 2001,411 (6837):599-603.
4Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease[J]. Nature, 2001, 411 (6837):603-606.
5Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations[J]. Lancet, 2001, 357(9272): 1925-1928.
6Kobayashi KS, Chamaillard M, Ogura Y, et al. NOD2-dependent regallation of innate and adaptive immunity in the intestinal tract[J]. Science, 2005, 307(5710):731-734.
7Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease[j]. Gastroenterology, 2002, 123(1):86-91.
8Leong RW, Armuzzi A, Ahmad T, et al. NOD2/CARD15 gene polymnrphisms and Crohn's disease in the Chinese population[J]. Aliment Pharmacol Ther, 2003, 17(12): 1465-1470.
9Arnott ID, Nimmo ER, Drummond HE, et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? [J]. Genes Immun, 2004, 5(5):417-425.
10Sugimura K, Taylor KD, Lin YC, et al. A novel NOD2/CARD 15 haplotype conferring risk for Crohn's disease in Ashkenazi Jews[J]. Am J Hum Genet, 2003, 72(3):509-518.
